Inactive Instrument

Proto Script Pharmaceutical Corp. Stock Other OTC

PSCR

US74373V1052

Valuation: Proto Script Pharmaceutical Corp.

Market Cap	1.97M 1.7M 1.59M 1.46M 2.74M 187M 2.78M 18.7M 7.33M 93.84M 7.38M 7.22M 313M	P/E 2015 *	-	P/E 2016	-41.4x
Enterprise Value	2.01M 1.74M 1.63M 1.49M 2.8M 192M 2.85M 19.15M 7.5M 96.12M 7.56M 7.39M 321M	EV / Sales 2015 *	-	EV / Sales 2016	394x
Free-Float	89.82%	Yield 2015 *	-	Yield 2016	-

* Estimated data More valuation ratios

Latest news : Proto Script Pharmaceutical Corp.

21/04/17	Proto Script Pharmaceutical Enters Partnership with PAKmed	CI
09/11/16	Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D	CI
07/11/16	Proto Script Pharmaceutical Corp. Announces Management Changes	CI
13/10/16	Yanex Group, Inc. will Change its Ticker to YNXGD from YNXG	CI
09/09/16	Yanex Group, Inc. Announces Management Changes	CI
09/09/16	Yanex Group Seeks Acquisitions	CI
06/07/16	Yanex Group, Inc. Reports Unaudited Consolidated Earnings Results for the Three Months Ended March 31, 2016	CI
05/07/16	Proto-Script Pharmaceuticals, Corp. acquired Yanex Group, Inc. in a reverse merger transaction.	CI
17/03/15	Michelle Rico acquired Proto-Script Pharmaceuticals Corp. from other stockholders.	CI
23/01/15	Proto-Script Pharmaceuticals Corp. agreed to acquire 49.29% in Wolverine Holding Corp. from Coral Capital Partners, Inc. for $0.06 million.	CI

More news

Managers and Directors: Proto Script Pharmaceutical Corp.

Manager	Title	Age	Since
Michelle Rico CEO	Chief Executive Officer	58	29/06/2016

More insiders

Other Business Support Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROTO SCRIPT PHARMACEUTICAL CORP.	-.--%	-43.33%	-	-	11.38K
CINTAS CORPORATION	+1.25%	+1.06%	-8.07%	+68.00%	81.12B
RB GLOBAL, INC.	-4.82%	-19.14%	-23.46%	+54.83%	17.38B
JACOBS SOLUTIONS INC.	+0.20%	+3.36%	-0.26%	+8.07%	17.24B
BUREAU VERITAS SA	-0.95%	-1.75%	+5.91%	+12.75%	14.57B
INTERTEK GROUP PLC	0.00%	0.00%	+24.95%	+37.35%	12.12B
ALS LIMITED	+0.09%	+7.47%	+26.88%	+97.31%	8.41B
ISS A/S	+4.40%	+0.28%	+53.89%	+131.71%	6.62B
GENPACT LIMITED	-0.53%	-4.86%	-21.27%	-8.42%	5.74B
DKSH HOLDING AG	0.00%	+1.47%	+20.21%	+1.92%	5.55B
Average	-0.05%	+746.66%	+8.75%	+44.83%	18.75B
Weighted average by Cap.	+0.32%	+559.91%	-0.62%	+52.74%

See all sector performances

Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.

Employees

Sector

Business Support Services

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

	2015	2016
Net sales	881K 764K 715K 652K 1.23M 84.07M 1.25M 8.38M 3.29M 42.08M 3.31M 3.24M 140M	789K 684K 640K 584K 1.1M 75.25M 1.12M 7.51M 2.94M 37.66M 2.96M 2.9M 126M
Net income	-145K -126K -118K -108K -202K -13.85M -206K -1.38M -541K -6.93M -545K -533K -23.13M	-7.18M -6.22M -5.83M -5.32M -10.01M -685M -10.17M -68.33M -26.77M -343M -26.97M -26.38M -1.14B
Net Debt	27.07K 23.46K 21.96K 20.04K 37.71K 2.58M 38.34K 257K 101K 1.29M 102K 99.42K 4.31M	47.78K 41.41K 38.77K 35.37K 66.56K 4.56M 67.68K 455K 178K 2.28M 179K 176K 7.61M